4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-160.87M
↓ 127% below average
Average (7y)
$-70.91M
Historical baseline
Range
High:$-9.55M
Low:$-160.87M
CAGR
+46.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-160.87M | -59.5% |
| 2023 | $-100.84M | +6.2% |
| 2022 | $-107.49M | -50.7% |
| 2021 | $-71.32M | -25.8% |
| 2020 | $-56.69M | -15.0% |
| 2019 | $-49.31M | -416.2% |
| 2018 | $-9.55M | +14.9% |
| 2017 | $-11.22M | - |